Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine

Haiyan Sun, Jung Hyang Sur, Sarah Sillman, David Steffen, Hiep L.X. Vu

Research output: Contribution to journalArticle

Abstract

The substantial genetic diversity exhibited by influenza A viruses of swine (IAV-S) represents the main challenge for the development of a broadly protective vaccine against this important pathogen. The consensus vaccine immunogen has proven an effective vaccinology approach to overcome the extraordinary genetic diversity of RNA viruses. In this project, we sought to determine if a consensus IAV-S hemagglutinin (HA) immunogen would elicit broadly protective immunity in pigs. To address this question, a consensus HA gene (designated H3-CON.1) was generated from a set of 1,112 H3 sequences of IAV-S recorded in GenBank from 2011 to 2015. The consensus HA gene and a HA gene of a naturally occurring H3N2 IAV-S strain (designated H3-TX98) were expressed using the baculovirus expression system and emulsified in an oil-in-water adjuvant to be used for vaccination. Pigs vaccinated with H3-CON.1 immunogen elicited broader levels of cross-reactive neutralizing antibodies and interferon gamma secreting cells than those vaccinated with H3-TX98 immunogen. After challenge infection with a fully infectious H3N2 IAV-S isolate, the H3-CON.1-vaccinated pigs shed significantly lower levels of virus in their nasal secretions than the H3-TX98-vaccinated pigs. Collectively, our data provide a proof-of-evidence that the consensus immunogen approach may be effectively employed to develop a broadly protective vaccine against IAV-S.

Original languageEnglish (US)
Article number108451
JournalVeterinary Microbiology
Volume239
DOIs
StatePublished - Dec 2019

Fingerprint

Influenza A virus
Hemagglutinins
hemagglutinins
Swine
Vaccines
vaccines
antigens
swine
H3N2 Subtype Influenza A Virus
Genes
genetic variation
genes
Baculoviridae
RNA Viruses
Nucleic Acid Databases
vaccine development
interferon-gamma
Neutralizing Antibodies
neutralizing antibodies
Nose

Keywords

  • Baculovirus expression
  • Hemagglutinin gene
  • Heterologous protection
  • Influenza A viruses of swine

ASJC Scopus subject areas

  • Microbiology
  • veterinary(all)

Cite this

Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine. / Sun, Haiyan; Sur, Jung Hyang; Sillman, Sarah; Steffen, David; Vu, Hiep L.X.

In: Veterinary Microbiology, Vol. 239, 108451, 12.2019.

Research output: Contribution to journalArticle

@article{164443cf3263407c9182f8ddc89ab9f8,
title = "Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine",
abstract = "The substantial genetic diversity exhibited by influenza A viruses of swine (IAV-S) represents the main challenge for the development of a broadly protective vaccine against this important pathogen. The consensus vaccine immunogen has proven an effective vaccinology approach to overcome the extraordinary genetic diversity of RNA viruses. In this project, we sought to determine if a consensus IAV-S hemagglutinin (HA) immunogen would elicit broadly protective immunity in pigs. To address this question, a consensus HA gene (designated H3-CON.1) was generated from a set of 1,112 H3 sequences of IAV-S recorded in GenBank from 2011 to 2015. The consensus HA gene and a HA gene of a naturally occurring H3N2 IAV-S strain (designated H3-TX98) were expressed using the baculovirus expression system and emulsified in an oil-in-water adjuvant to be used for vaccination. Pigs vaccinated with H3-CON.1 immunogen elicited broader levels of cross-reactive neutralizing antibodies and interferon gamma secreting cells than those vaccinated with H3-TX98 immunogen. After challenge infection with a fully infectious H3N2 IAV-S isolate, the H3-CON.1-vaccinated pigs shed significantly lower levels of virus in their nasal secretions than the H3-TX98-vaccinated pigs. Collectively, our data provide a proof-of-evidence that the consensus immunogen approach may be effectively employed to develop a broadly protective vaccine against IAV-S.",
keywords = "Baculovirus expression, Hemagglutinin gene, Heterologous protection, Influenza A viruses of swine",
author = "Haiyan Sun and Sur, {Jung Hyang} and Sarah Sillman and David Steffen and Vu, {Hiep L.X.}",
year = "2019",
month = "12",
doi = "10.1016/j.vetmic.2019.108451",
language = "English (US)",
volume = "239",
journal = "Veterinary Microbiology",
issn = "0378-1135",
publisher = "Elsevier",

}

TY - JOUR

T1 - Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine

AU - Sun, Haiyan

AU - Sur, Jung Hyang

AU - Sillman, Sarah

AU - Steffen, David

AU - Vu, Hiep L.X.

PY - 2019/12

Y1 - 2019/12

N2 - The substantial genetic diversity exhibited by influenza A viruses of swine (IAV-S) represents the main challenge for the development of a broadly protective vaccine against this important pathogen. The consensus vaccine immunogen has proven an effective vaccinology approach to overcome the extraordinary genetic diversity of RNA viruses. In this project, we sought to determine if a consensus IAV-S hemagglutinin (HA) immunogen would elicit broadly protective immunity in pigs. To address this question, a consensus HA gene (designated H3-CON.1) was generated from a set of 1,112 H3 sequences of IAV-S recorded in GenBank from 2011 to 2015. The consensus HA gene and a HA gene of a naturally occurring H3N2 IAV-S strain (designated H3-TX98) were expressed using the baculovirus expression system and emulsified in an oil-in-water adjuvant to be used for vaccination. Pigs vaccinated with H3-CON.1 immunogen elicited broader levels of cross-reactive neutralizing antibodies and interferon gamma secreting cells than those vaccinated with H3-TX98 immunogen. After challenge infection with a fully infectious H3N2 IAV-S isolate, the H3-CON.1-vaccinated pigs shed significantly lower levels of virus in their nasal secretions than the H3-TX98-vaccinated pigs. Collectively, our data provide a proof-of-evidence that the consensus immunogen approach may be effectively employed to develop a broadly protective vaccine against IAV-S.

AB - The substantial genetic diversity exhibited by influenza A viruses of swine (IAV-S) represents the main challenge for the development of a broadly protective vaccine against this important pathogen. The consensus vaccine immunogen has proven an effective vaccinology approach to overcome the extraordinary genetic diversity of RNA viruses. In this project, we sought to determine if a consensus IAV-S hemagglutinin (HA) immunogen would elicit broadly protective immunity in pigs. To address this question, a consensus HA gene (designated H3-CON.1) was generated from a set of 1,112 H3 sequences of IAV-S recorded in GenBank from 2011 to 2015. The consensus HA gene and a HA gene of a naturally occurring H3N2 IAV-S strain (designated H3-TX98) were expressed using the baculovirus expression system and emulsified in an oil-in-water adjuvant to be used for vaccination. Pigs vaccinated with H3-CON.1 immunogen elicited broader levels of cross-reactive neutralizing antibodies and interferon gamma secreting cells than those vaccinated with H3-TX98 immunogen. After challenge infection with a fully infectious H3N2 IAV-S isolate, the H3-CON.1-vaccinated pigs shed significantly lower levels of virus in their nasal secretions than the H3-TX98-vaccinated pigs. Collectively, our data provide a proof-of-evidence that the consensus immunogen approach may be effectively employed to develop a broadly protective vaccine against IAV-S.

KW - Baculovirus expression

KW - Hemagglutinin gene

KW - Heterologous protection

KW - Influenza A viruses of swine

UR - http://www.scopus.com/inward/record.url?scp=85073621435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073621435&partnerID=8YFLogxK

U2 - 10.1016/j.vetmic.2019.108451

DO - 10.1016/j.vetmic.2019.108451

M3 - Article

C2 - 31767095

AN - SCOPUS:85073621435

VL - 239

JO - Veterinary Microbiology

JF - Veterinary Microbiology

SN - 0378-1135

M1 - 108451

ER -